These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38628642)

  • 1. Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy.
    Liang T; Lin C; Ning H; Qin F; Zhang B; Zhao Y; Cao T; Jiao S; Chen H; He Y; Cai H
    Front Pharmacol; 2024; 15():1349043. PubMed ID: 38628642
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia.
    Rakitin A; Eglit T; Kõks S; Lember M; Haldre S
    PLoS One; 2014; 9(7):e103856. PubMed ID: 25078464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid.
    Nisha Y; Bobby Z; Wadwekar V
    Seizure; 2018 Aug; 60():57-60. PubMed ID: 29906708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic Acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none?
    Zuo S; Fries BE; Szafara K; Regal R
    P T; 2015 Feb; 40(2):126-32. PubMed ID: 25673963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
    Hamed SA; Fida NM; Hamed EA
    Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy.
    Ma B; Yang K; Li X; Su N; Yu T; Zou Y; Xu X; Wang F; Cheng J; Yan Z; Chen T; Zhang L
    Ther Drug Monit; 2024 Aug; 46(4):503-511. PubMed ID: 38287884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
    Bromley R; Weston J; Adab N; Greenhalgh J; Sanniti A; McKay AJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010236. PubMed ID: 25354543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Valproic Acid and Its Main Metabolites' Plasma Concentrations with Clinical Outcomes among Epilepsy Patients: A 10-Year Retrospective Study Based on Therapeutic Drug Monitoring.
    Li RT; Chen ZY; Tang SY; Wen DS; Ren RN; Zhang XX; Liu SZ; Zhou S; Wang XD; Zhou LM; Huang M
    Drug Metab Dispos; 2024 Feb; 52(3):210-217. PubMed ID: 38195521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy.
    Kwack DW; Kim DW
    Clin Neurol Neurosurg; 2023 Oct; 233():107962. PubMed ID: 37717359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis.
    Nakashima H; Oniki K; Nishimura M; Ogusu N; Shimomasuda M; Ono T; Matsuda K; Yasui-Furukori N; Nakagawa K; Ishitsu T; Saruwatari J
    PLoS One; 2015; 10(10):e0141266. PubMed ID: 26484865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
    Sidhu HS; Srinivas R; Sadhotra A
    Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with blood carnitine levels in adult epilepsy patients with chronic valproic acid therapy.
    Saito M; Takizawa T; Miyaoka H
    Epilepsy Res; 2021 Sep; 175():106697. PubMed ID: 34175794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics?
    Miranda Herrero MC; Alcaraz Romero AJ; Escudero Vilaplana V; Fernández Lafever SN; Fernández-Llamazares CM; Barredo Valderrama E; Vázquez López M; de Castro P
    Eur J Paediatr Neurol; 2015 Mar; 19(2):155-61. PubMed ID: 25578527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Importance of Monitoring Unbound Valproic Acid Concentration in Patients with Hypoalbuminemia.
    Doré M; San Juan AE; Frenette AJ; Williamson D
    Pharmacotherapy; 2017 Aug; 37(8):900-907. PubMed ID: 28574586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of CYP2C9-status guided valproic acid therapy in children.
    Bűdi T; Tóth K; Nagy A; Szever Z; Kiss Á; Temesvári M; Háfra E; Garami M; Tapodi A; Monostory K
    Epilepsia; 2015 Jun; 56(6):849-55. PubMed ID: 25967074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety range of free valproic acid serum concentration in adult patients.
    Tseng YJ; Huang SY; Kuo CH; Wang CY; Wang KC; Wu CC
    PLoS One; 2020; 15(9):e0238201. PubMed ID: 32877431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid.
    Ozdemir O; Yakut A; Dinleyici EC; Aydogdu SD; Yarar C; Colak O
    Eur J Pediatr; 2011 Jul; 170(7):873-7. PubMed ID: 21140275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of metformin and sub-therapeutic dose of valproic acid prevent valproic acid-induced toxicity in animal model of epilepsy.
    Jamal M; Azam M; Simjee SU
    Drug Chem Toxicol; 2024 May; 47(3):287-295. PubMed ID: 36650908
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.